Ralf Böthig

Ralf Böthig

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2017 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
RBRalf Böthig
Ralf Böthig
IKInes Kurze
Ines Kurze
KFKai Fiebag
Kai Fiebag
AKAlbert Kaufmann
Albert Kaufmann
WSWolfgang Schöps
Wolfgang Schöps
KGKlaus Golka
Klaus Golka

13 January 2020 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
RBRalf Böthig
Ralf Böthig
CTChristian Tiburtius
Christian Tiburtius
KFKai Fiebag
Kai Fiebag
BKBirgitt Kowald
Birgitt Kowald
SHSven Hirschfeld
Sven Hirschfeld
KGKlaus Golka
Klaus Golka

29 April 2021 in Military Medical Research
Verified
Journal Article
Open access
PDF file
RBRalf Böthig
Ralf Böthig
CTChristian Tiburtius
Christian Tiburtius
WSWolfgang Schöps
Wolfgang Schöps
MZMichael Zellner
Michael Zellner
OBOliver Balzer
Oliver Balzer
KGKlaus Golka
Klaus Golka
Background: Traumatic spinal cord injury (SCI) is also a combat-related injury that is increasing in modern warfare. The aim of this work is to inform medical experts regarding the different course of bladder cancer in able-bodied patients compared with SCI patients based on the latest medical scientific knowledge, and to present decision-making aids for the assessment of bladder cancer as a late sequela of traumatic SCI. Methods: A study conducted between January 1998 and December 2019 in the BG Trauma Hospital Hamburg formed the basis for the decision-making aids. Urinary bladder cancer was diagnosed in 40 out of 7396 treated outpatient and inpatient SCI patients. General patient information, latency period, age at initial diagnosis, type of bladder management and survival of SCI patients with bladder cancer were collected and analysed. T category, grading and tumour entity in these patients were compared with those in the general population. Relevant bladder cancer risk factors in SCI patients were analysed. Furthermore, relevant published literature was taken into consideration. Results: Initial diagnosis of urinary bladder cancer in SCI patients occurs at a mean age of 56.4 years (SD ± 10.7 years), i.e. , approximately 20 years earlier as compared with the general population. These bladder cancers are significantly more frequently muscle invasive (i.e., T category ≥ T2) and present a higher grade at initial diagnosis. Furthermore, SCI patients show a significantly higher proportion of the more aggressive squamous cell carcinoma than that of the general population in areas not endemic for the tropical disease schistosomiasis. Consequently, the survival time is extremely unfavourable. A very important finding, for practical reasons is that, in the Hamburg study as well as in the literature, urinary bladder cancer is more frequently observed after 10 years or more of SCI. Based on these findings, a matrix was compiled where the various influencing factors, either for or against the recognition of an association between SCI and urinary bladder cancer, were weighted according to their relevance. Conclusions: The results showed that urinary bladder cancer in SCI patients differs considerably from that in able-bodied patients. The presented algorithm is an important aid in everyday clinical practice for assessing the correlation between SCI and bladder cancer.


29 January 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AEAnton Emmanuel
Anton Emmanuel
IKInes Kurze
Ines Kurze
KKKlaus Krogh
Klaus Krogh
MVMaria Elena Ferreiro Velasco
Maria Elena Ferreiro Velasco
PCPeter Christensen
Peter Christensen
MVMiguel Angel Gonzalez Viejo
Miguel Angel Gonzalez Viejo
Background: Transanal irrigation (TAI) has emerged as a key option when more conservative bowel management does not help spinal cord injured (SCI) individuals with neurogenic bowel dysfunction (NBD). Aim: To investigate the short-term efficacy and safety of an electronic TAI system (Navina Smart) in subjects with NBD. Design: We present an open, prospective efficacy study on Navina Smart, in individuals with NBD secondary to SCI, studied at three months. Population: Eighty-nine consecutive consenting established SCI individuals (61 male; mean age 48, range 18–77) naïve to TAI treatment were recruited from ten centres in seven countries. Subjects had confirmed NBD of at least moderate severity (NBD score ≥10). Methods: Subjects were taught how to use the device at baseline assisted by the Navina Smart app, and treatment was tailored during phone calls until optimal TAI regime was achieved. The NBD score was measured at baseline and at three months follow up (mean 98 days). Safety analysis was performed on the complete population while per protocol (PP) analysis was performed on 52 subjects. Results: PP analysis showed a significant decrease in mean NBD score (17.8 to 10, p<0.00001). In subjects with severe symptoms (defined as NBD score ≥14), mean NBD scores decreased (19.4 to 10.9, p<0.0001). The number of subjects with severe symptoms decreased from 41 (79%) subjects at baseline to 16 (31%) at three months follow-up. Device failure accounted for the commonest cause for loss of data. Side effects possibly related to the device developed in 11 subjects (12%). Discontinuation due to failure of therapy to relieve symptoms was reported by 5 subjects (6%). Conclusion: Navina Smart is effective for individuals with NBD, even those with severe symptoms; long-term data will follow. Whilst there were some device problems (addressed by the later stages of subject recruitment) the treatment was generally safe. Clinical trial: (ClinicalTrials.gov number NCT02979808)

22 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RTRoland Thietje
Roland Thietje
BKBirgitt Kowald
Birgitt Kowald
RBRalf Böthig
Ralf Böthig
ASArndt Peter Schulz
Arndt Peter Schulz
MNMarkus Northmann
Markus Northmann
SHSven Hirschfeld
Sven Hirschfeld
To study the mortality, cause and risk indicators of death in German patients with traumatic spinal cord injury, patients with traumatic spinal cord injury admitted to Berufsgenossenschaftliches Trauma Hospital Hamburg between 1 January 1997 and 31 December 2018, aged between 16 and 60 with a minimal survival of one year after injury, were included. Further criteria were the absence of life-limiting comorbidities at the time of injury. 223 deceased patients with traumatic spinal cord injury were identified, investigated on and partly compared to the surviving subjects. We aimed to discover specific complications that were related to Spinal Cord Injury and responsible for a possibly limited life expectancy. Data collection was performed during in- and outpatient treatment. A statistical analysis was performed to compare groups. The post-injury life expectancy was 25.0 years with a significant correlation regarding the level of lesion and severity of injury. The leading causes of death were cardiovascular diseases and pneumonia. Bladder cancer was the most common fatal malignant tumor. The life expectancy of patients suffering from traumatic spinal cord injury is limited. The longer a patient survives after injury and the lower the level of lesion, the more likely an age-related cause of death becomes. Bladder cancer is significantly more frequent when compared to the overall distribution of tumor diseases in Germany.